This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Hlk Pharmaceuticals Co., Ltd., Yunnan Institute of Materia Medica. Active years: 2019.
Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2019
Title: Biography of Inventor Wenqiang Sun
Introduction: Wenqiang Sun is a notable inventor based in Yunnan, China. He has made significant contributions to the field of medicine and the chemical industry, particularly through his innovative work on scutellarin aglycone.
Latest Patents: Wenqiang Sun holds a patent for "Crystal forms of scutellarin aglycone and preparation thereof." This invention addresses the need for multiple crystal forms of scutellarin aglycone, which are crucial for the development of medicaments aimed at preventing and treating cardiovascular or cerebrovascular diseases, rheumatic arthritis, and stroke sequelae. The crystal forms he developed exhibit good stability and effectively tackle issues related to poor oral absorption and low bioavailability of scutellarin.
Career Highlights: Throughout his career, Wenqiang Sun has worked with esteemed organizations such as the Yunnan Institute of Materia Medica and Hlk Pharmaceuticals Co., Ltd. His expertise in the field has led to advancements that benefit both the medical community and patients.
Collaborations: Wenqiang has collaborated with several professionals in his field, including Zeren Wang and Jun Xu. These partnerships have fostered innovation and contributed to the successful development of his patented technologies.
Conclusion: Wenqiang Sun's work exemplifies the impact of innovation in medicine. His contributions to the understanding and application